Alembic Pharmaceuticals (Alembic) announced that it has received Final Approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Diltiazem ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback